Back to search

Article

Innovation Institutions and COVID-19, Part II

2022-07-08

Abstract excerpt

The COVID-19 crisis has starkly illustrated both the strengths and limitations of U.S. biomedical innovation institutions as deployed to fight a pandemic. These innovation institutions include not just intellectual property law, but also other legal systems that structure incentives for production and allocation of knowledge goods, including regulation by health agencies like the Food and Drug Administration, prog...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
18ac1eaa-e42d-575b-af70-32369d4841c6
DOI
10.2139/ssrn.4149035
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Innovation Institutions and COVID-19, Part IIDOI 10.2139/ssrn.4149035
Innovation Institutions and COVID-19Semantic proximity
The Intellectual Property of COVID-19Semantic proximity
Technological Exaptation to Support Innovation for COVID-19 Pandemic CrisisSemantic proximity
Innovation for challenges of public health and sustainable growthSemantic proximity
<strong>COVID19 PCR Testing and the Unprecedented Institutional Response in a Low-Resource Setting</strong>Semantic proximity
The Birth of the Research Field of COVID-19: Factors Determining the Evolution Supporting Discoveries and Technological Paradigm Shift with New MRNA VaccinesSemantic proximity
Analysis of recurrent research pathways for assessing and improving effectiveness in life sciences laboratoriesSemantic proximity
Addressing Exclusivity Issues During the COVID-19 Pandemic and BeyondSemantic proximity
How confidence in health care systems affects mobility and compliance during the COVID-19 pandemicSemantic proximity
Innovation Incentives in the Pharmaceutical Sector: Re-thinking Competition and Public Policy?Semantic proximity
Promoting Vaccine InnovationSemantic proximity
The Future of Artificial Intelligence in International Healthcare: An IndexSemantic proximity
Select a neighboring publication to make it the new centre.